Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis

BACKGROUND: Although heart failure with preserved ejection fraction (HFpEF) is a serious disease, only limited options are available for its treatment. Recent studies have analyzed the effects of phosphodiesterase (PDE) inhibitors, especially PDE5 and PDE3 inhibitors, in patients with HFpEF, with mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhu, Zhao, Kaixuan, Xiao, Changhu, He, Ziyu, Liu, Sha, Wu, Xuemei, Shi, Shuting, Guo, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508622/
https://www.ncbi.nlm.nih.gov/pubmed/36164567
http://dx.doi.org/10.1016/j.jsps.2022.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508622/
https://www.ncbi.nlm.nih.gov/pubmed/36164567
http://dx.doi.org/10.1016/j.jsps.2022.05.012

Ejemplares similares